If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN. There is no cost or obligation… Continue reading BEAUTY HEALTH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options
Category: Newswire
NUSCALE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In NuScale To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in NuScale securities between March 15, 2023 and November 8, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SMR. There is no cost or obligation to… Continue reading NUSCALE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In NuScale To Contact Him Directly To Discuss Their Options
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sweetgreen, Inc. – SG
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sweetgreen, Inc. (“Sweetgreen” or the “Bank”) (NYSE: SG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Sweetgreen and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sweetgreen, Inc. – SG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amylyx Pharmaceuticals, Inc. – AMLX
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) (NASDAQ: AMLX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Amylyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amylyx Pharmaceuticals, Inc. – AMLX
FISKER ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fisker To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Fisker securities between August 4, 2023 and November 20, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FSR. There is no cost or obligation to… Continue reading FISKER ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fisker To Contact Him Directly To Discuss Their Options
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DMC Global Inc. – BOOM
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DMC and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DMC Global Inc. – BOOM
Freedom, Equality and Justice Lead to Peace
Human Rights Day Statement by Education Cannot Wait Executive Director Yasmine Sherif NEW YORK, Dec. 10, 2023 /PRNewswire/ — Today we mark a milestone in history: the 75th anniversary of the Universal Declaration of Human Rights. As people around the world commemorate Human Rights Day, we must also deeply reflect on the meaning of this… Continue reading Freedom, Equality and Justice Lead to Peace
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Expensify, Inc. of Class Action Lawsuit and Upcoming Deadline – EXFY
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Expensify, Inc. (“Expensify” or the “Company”) (NASDAQ: EXFY) and certain officers. The class action, filed in the United States District Court for the District of Oregon, and docketed under 23-cv-01784, is on behalf of a class… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Expensify, Inc. of Class Action Lawsuit and Upcoming Deadline – EXFY
FARFETCH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Farfetch To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Farfetch securities between March 9, 2023 and August 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FTCH. There is no cost or obligation to… Continue reading FARFETCH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Farfetch To Contact Him Directly To Discuss Their Options
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On InMode Ltd.- INMD
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether InMode and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On InMode Ltd.- INMD